Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis

Nutrients. 2015 Feb 27;7(3):1480-93. doi: 10.3390/nu7031480.

Abstract

The antidiabetic effect of a hot water extract of stems of Salacia chinensis (SCE) was evaluated in vivo in KK-Ay mice, a typical type 2 diabetes mellitus mice model. Administration of CE-2 dietary feed containing 0.25 and/or 0.50% of SCE for three weeks to KK-Ay mice significantly suppressed the elevation of both blood glucose and HbA1c levels without significant changes in body weight or food intake. Glucose tolerance was improved by administration to KK-Ay mice for 27 days of AIN93M purified dietary feed containing 0.12% of SCE. No suppressive effect with respect to HbA1c level was observed when AIN93M/Glc dietary feed in which all digestible glucides were replaced with glucose was administered with SCE. Thus, α-glucosidase inhibitory activity approved as the mechanism of action of the antidiabetic effect of SCE by in vitro investigation was reconfirmed also in in vivo studies. Evaluation of the α-glucosidase inhibitory activity of the active constituents, salacinol (1), kotalanol (3), and neokotalanol (4), by employing human α-glucosidases revealed that these compounds inhibited them as potently (IC50 = 3.9-4.9 μM for maltase) as they inhibited rat small intestinal α-glucosidase. The principal sulfonium constituents (1-4) were highly stable in an artificial gastric juice. In addition, 1-4 were hardly absorbed from the intestine in an experiment using the in situ rat ligated intestinal loop model. The results indicate that these sulfoniums are promising leads for a new type of anti-diabetic agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Disease Models, Animal
  • Glycated Hemoglobin / metabolism
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Glycoside Hydrolase Inhibitors / therapeutic use*
  • Humans
  • Intestine, Small / metabolism
  • Male
  • Mice
  • Monosaccharides / pharmacology
  • Monosaccharides / therapeutic use*
  • Phytotherapy*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Salacia / chemistry*
  • Sugar Alcohols / pharmacology
  • Sugar Alcohols / therapeutic use*
  • Sulfates / pharmacology
  • Sulfates / therapeutic use*
  • Sulfonium Compounds / pharmacology
  • Sulfonium Compounds / therapeutic use
  • alpha-Glucosidases / metabolism

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Glycoside Hydrolase Inhibitors
  • Kotalanol
  • Monosaccharides
  • Plant Extracts
  • Sugar Alcohols
  • Sulfates
  • Sulfonium Compounds
  • salacinol
  • alpha-Glucosidases